Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial | |
Li, Jian-wei; Liu, Guang-yu; Ji, Ya-jie; Yan, Xia; Pang, Da; Jiang, Ze-fei; Chen, De-dian; Zhang, Bin; Xu, Bing-he; Shao, Zhi-ming | |
刊名 | CANCER MANAGEMENT AND RESEARCH |
2019 | |
卷号 | 11 |
关键词 | breast cancer adjuvant therapy anastrozole tamoxifen GnRH analogs aromatase inhibitors |
ISSN号 | 1179-1322 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3413514 |
专题 | 昆明医科大学 |
推荐引用方式 GB/T 7714 | Li, Jian-wei,Liu, Guang-yu,Ji, Ya-jie,et al. Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial[J]. CANCER MANAGEMENT AND RESEARCH,2019,11. |
APA | Li, Jian-wei.,Liu, Guang-yu.,Ji, Ya-jie.,Yan, Xia.,Pang, Da.,...&Shao, Zhi-ming.(2019).Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial.CANCER MANAGEMENT AND RESEARCH,11. |
MLA | Li, Jian-wei,et al."Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial".CANCER MANAGEMENT AND RESEARCH 11(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论